Global Market Research Group

"Retail Banking Country Snapshot: China" The Report covers current Market Trends, Analysis, Forecast, Review, Share, Size, Growth, Effect. Description- Summary The Chinese banking market is opening up to new entrants in order to encourage greater competition within the sector, and investment in banking infrastructure is likely to speed up digital expansion. The market for financial services in China is concentrated, with an oligopoly of five banks that service 72% of the market. Younger age groups use branches more often, meaning there is considerable scope for providers to encourage greater use of digital channels. Key Findings - The top six providers have a 70% share of the China current account market. Branch location and reputation are the most influential factors driving choice of provider, giving established banks an advantage over digital-only entrants. Younger families claim to be the likeliest segment to switch provider over the next 12 months

"Global Stem Cell Banking Sales Market Report to 2021" The Report covers current Market Trends, Analysis, Forecast, Review, Share, Size, Growth, Effect. Description- Notes: Sales, means the sales volume of Stem Cell Banking Revenue, means the sales value of Stem Cell Banking This report studies sales (consumption) of Stem Cell Banking in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering CBR Systems, Inc. Cordlife Cryo-Cell Cryo-Save AG (A Group of Esperite) Lifecell Stemcyte Viacord Smart Cells International Ltd. Cryoviva India Cordvida China Cord Blood Corporation Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Stem Cell Banking in these regions, from 2011 to 2021 (